Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: Phase I/II Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung Cancer [NA]
A Phase I/II neoadjuvant study evaluating cemiplimab in combination with dupilumab in patients with early-stage non-small cell lung cancer; …
-
CLINICAL_TRIALS research · 2024-12-19Clinical Trial Update: A Study of IBI363 in Subjects with Advanced Solid Malignancies [Phase 2]
Phase 2 study of IBI363 in advanced solid malignancies is currently recruiting, with indications including melanoma, non-small cell lung can…
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer [Phase 3]
An ongoing Phase 3 clinical trial comparing photon therapy to proton therapy for non-small cell lung cancer. The study is currently ACTIVE_N…
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors [Phase 1]
This Phase 1 clinical trial update evaluates CAR-macrophages targeting HER2-overexpressing solid tumors, sponsored by Carisma Therapeutics. …
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of Pulsed Electric Field Ablation Devices in the Treatment of Lung Tumors [NA]
A clinical trial update describes evaluating the efficacy and safety of pulsed electric field ablation devices for treating lung tumors, inc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: PRedictive Value of Multiparametric Dynamic WB 18F-FDG-PET Imaging on a LAFOV System for FIRST-line Chemo-immunotherapy Efficacy in Advanced Non-small-cell Lung Cancer: PROFIL-1
This clinical trial investigates the predictive value of multiparametric dynamic whole-body 18F-FDG-PET imaging on a long-axial FOV system f…
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: The Diagnostic Value of Bronchoscopic Needle-based Confocal Laser Endomicroscopy (nCLE) As a Real-time Detection Tool for Diagnosing Peripheral Lung Cancer: a Multi-centre Randomised Controlled Trial [NA]
This clinical trial evaluates the diagnostic value of bronchoscopic needle-based confocal laser endomicroscopy (nCLE) as a real-time tool to…
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: Cross-sectorial Rehabilitation of Patients with Lung Cancer [NA]
An ongoing clinical trial examining cross-sector rehabilitation for patients with non-small cell lung cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: Multicenter Analysis of Different Approaches in Segmentectomies in Early-stage Lung Cancer
A multicenter trial is recruiting to compare different segmentectomy approaches for early-stage lung cancer, including non-small cell lung c…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: A Multicenter Real-world Clinical Study on the Efficacy and Safety of Ensartinib As Neoadjuvant Treatment for Anaplastic Lymphoma Kinase (ALK) Positive Non-small Cell Lung Cancer (NSCLC) Patients.
The document describes a multicenter real-world study evaluating ensartinib as neoadjuvant therapy for ALK-positive non-small cell lung canc…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Neoadjuvant Envafolimab Plus Disitamab Vedotin and Carboplatin in Resectable HER2-Mutant Non-Small-Cell Lung Cancer [Phase 2]
A Phase 2 neoadjuvant trial is evaluating Envafolimab in combination with Disitamab Vedotin and Carboplatin for resectable HER2-mutant non-s…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Adebrelimab Plus Chemo and Recaticimab in Perioperative Treatment of Resectable NSCLC [Phase 2]
Phase 2 clinical trial evaluating adebrelimab plus chemotherapy and recaticimab as perioperative treatment for resectable non-small cell lun…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Tumoral Bone Strength Assessment by Numerical Simulation Using Quantitative CT : the MEKANOS Study
MEKANOS is a clinical trial evaluating tumoral bone strength using numerical simulation with quantitative CT in patients with bone metastase…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Study of Tislelizumab and Platinum-based Chemotherapy Combination With H1 Receptor Antagonist（Diphenhydramine）in Advanced and Metastatic Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 study evaluating tislelizumab in combination with platinum-based chemotherapy for advanced and metastatic non-small cell lung canc…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: A Clinical Study of JMT101 in Combination With Osimertinib Versus Osimertinib Alone as First-Line Treatment for Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Sensitive Mutations [Phase 3]
A Phase 3 clinical trial evaluating JMT101 in combination with osimertinib versus osimertinib alone as first-line therapy for locally advanc…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: MRNA Neoantigen Vaccine in Non-Small Cell Lung Cancer [EARLY_Phase 1]
An early-phase 1 clinical trial is testing an mRNA neoantigen vaccine for non-small cell lung cancer, with recruitment not yet started.
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: A Study Developing a Non-invasive Urine-based Proteomic Model for Early Lung Cancer Detection.
A clinical trial update describing the development of a non-invasive urine-based proteomic model for early detection of lung cancer, includi…
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Glycoprotein in Immunotherapy Response and Efficacy Prediction of Lung Cancer
A recruiting clinical trial at Shanghai Chest Hospital is evaluating a glycoprotein as a biomarker to predict immunotherapy response and eff…
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Tumor-specific T Cells in Lung Cancer [NA]
A clinical trial update indicates a study evaluating tumor-specific T cells for non-small cell lung cancer is currently active but not recru…
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: Evaluation of the Efficacy and Safety of Furmonertinib Combined with Bevacizumab As First-Line Treatment for EGFR-Positive Non-Small Cell Lung Cancer with Brain Metastases: a Single-Arm, Open-Label, Prospective Phase II Clinical Study [Phase 2]
Phase II single-arm study evaluating furmonertinib plus bevacizumab as first-line therapy for EGFR-mutant non-small cell lung cancer with br…
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: Efficacy and Safety of Vorolanib Monotherapy As Third-line or Later Treatment for Advanced Non-small Cell Lung Cancer Patients: a Single-arm, Prospective, Open-label Phase II Clinical Study [Phase 2]
A Phase II single-arm study evaluating vorolanib as third-line or later monotherapy for advanced non-small cell lung cancer; the trial is cu…
-
CLINICAL_TRIALS research · 2024-12-10Clinical Trial Update: Cognitive Screening in Lung Cancer Patients
A clinical trial investigating cognitive screening in lung cancer patients is currently recruiting, including non-small cell and small cell …
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors [Phase 2]
This clinical trials update describes a multicenter, open-label Phase IIa study to evaluate the efficacy and safety of B1962 injections in a…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Using ctDNA to Detect Minimal Residual Disease After Lung Cancer Resection
A clinical trial is evaluating whether circulating tumor DNA can detect minimal residual disease after surgical resection of non-small cell …
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: The Efficacy and Safety of Adjuvant Immunotherapy After Pathological Complete Response Following Neoadjuvant Chemoimmunotherapy in Patients with Resectable NSCLC
This clinical trial update discusses the efficacy and safety of adjuvant immunotherapy after pathological complete response following neoadj…